Multimorbidity and complex multimorbidity in Brazilians with severe obesity

To investigate the prevalence of multimorbidity and complex multimorbidity and their association with sociodemographic and health variables in individuals with severe obesity. This is a baseline data analysis of 150 individuals with severe obesity (body mass index ≥ 35.0 kg/m2) aged 18-65 years. The outcomes were multimorbidity and complex multimorbidity. Sociodemographic, lifestyle, anthropometric and self-perceived health data were collected. Poisson multiple regression was conducted to identify multimorbidity risk factors. The frequency of two or more morbidities was 90.7%, three or more morbidities was 76.7%, and complex multimorbidity was 72.0%. Living with four or more household residents was associated with ≥ 3 morbidities and complex multimorbidity. Fair and very poor self-perceived health was associated with ≥ 2 morbidities, ≥ 3 morbidities and complex multimorbidity. A higher BMI range (45.0-65.0 kg/m2) was associated with ≥ 2 morbidities and ≥ 3 morbidities. Anxiety (82.7%), varicose veins of lower limbs (58.7%), hypertension (56.0%) were the most frequent morbidities, as well as the pairs and triads including them. The prevalence of multimorbidity and complex multimorbidity in individuals with severe obesity was higher and the risk for multimorbidity and complex multimorbidity increased in individuals living in households of four or more residents, with fair or poor/very poor self-perceived health and with a higher BMI.

Overweight, obesity and risk of multimorbidity: A systematic review and meta-analysis of longitudinal studies

This study aimed to review and quantify the association between overweight and obesity in the risk of multimorbidity among the general population. We conducted a systematic review and meta-analysis in the databases of Pubmed, Lilacs, Web of Science, Scopus, and Embase. We included cohort studies that assessed the association between overweight and/or obesity with the risk of multimorbidity. The Newcastle-Ottawa assessed the studies' individual quality. A random-effect model meta-analysis was performed to evaluate the association between overweight and obesity with the relative risk (RR) of multimorbidity; the I² test evaluated heterogeneity. After excluding duplicates, we found 1.655 manuscripts, of which eight met the inclusion criteria. Of these, seven (87.5%) evidenced an increased risk of multimorbidity among subjects with overweight and/or obesity. Overall, we observed an increased risk of multimorbidity among subjects with overweight (RR: 1.26; CI95%: 1.12; 1.40, I²  = 98%) and obesity (RR: 1.99; CI95%: 1.45;2.72, I²  = 99%) compared to normal weight. According to the I² test, the heterogeneities of the meta-analyses were high. The Newcastle-Ottawa scale showed that all studies were classified as high quality. Further longitudinal studies are needed, including different populations and stratifications by sex, age, and other variables.

Prevalence of constipation in adults with obesity class II and III and associated factors

Background

Constipation and obesity have common risk factors. However, little is known about the occurrence of constipation in individuals with severe obesity and the associated factors.

Objective

To evaluate the prevalence of intestinal constipation and its associated factors in adults with obesity class II and III.

Method

This study analyzed baseline data from a randomized clinical trial with adults aged 18–64 with a Body Mass Index (BMI) ≥ 35 kg/m², living in the metropolitan region of Goiânia, Brazil. Data were collected using a questionnaire containing sociodemographic, lifestyle, level of obesity, presence of comorbidities, water intake and food consumption variables. The outcome variable was constipation assessed by the Rome III criteria and the Bristol Stool Form Scale. Multiple Poisson regression analysis was used to assess the association between explanatory variables and the outcome.

Results

Among the 150 participants, the prevalence of constipation was 24.67% (95% CI: 17.69–31.64). After multiple regression analyses constipation was associated with polypharmacy (adjusted PR: 2.99, 95% CI: 1.18–7.57, p = 0.021), younger age group i.e. 18–29 years (adjusted PR: 3.12, 95% CI: 1.21–8.06, p = 0.019) and former smoking (adjusted PR: 3.24, 95% CI: 1.28–9.14, p = 0.014). There was no statistically significant association between constipation and daily consumption of fiber-rich foods, however, the non-consumption of whole grains was borderline significant (adjusted PR: 2.92, 95% CI: 1.00 to 8.49, p = 0.050).

Conclusion

A high prevalence of constipation was found in adults with obesity class II and III. Constipation was significantly associated with the simultaneous use of five or more medications, younger age group and being a former smoker.

The Risk of Multimorbidity Associated with Overweight and Obesity: Data from the Brazilian National Health Survey 2013

Background

An increase in body mass index (BMI) is strongly associated with the occurrence of multimorbidity, and overweight and obesity are contributing factors for the increase in morbidities. Thus, the present study aimed to evaluate the occurrence of multimorbidity and associated factors in Brazilian adults with and without overweight or obesity.

Methods

This was a cross-sectional population-based study with data from the National Health Survey (2013) including individuals aged 18 years or older. Multimorbidity was defined as having ≥2 diseases from the list of 15 morbidities on the self-reported questionnaire (self-reported medical diagnosis in life). BMI was categorized as: ≤24.9 kg/m² (low weight and eutrophy), 25.0–29.9 kg/m² (overweight), and ≥30.0 kg/m² (obesity). Sex, age, and schooling were the covariates. Poisson regression was used for crude and adjusted analyses for the variables representing access to health services estimating the prevalence ratio (PR) and 95% confidence interval (CI).

Results

The total sample consisted of 59,402 individuals. The prevalence of multimorbidity was 25% overall and was higher among overweight (25.8%) and obese (32.5%) individuals. Obese women 60 years or older had a higher occurrence of multimorbidity (80%). In the adjusted analysis, a lower prevalence of multimorbidity was observed among those with higher educational levels in all BMI classifications: low weight/eutrophy, PR=0.66 (95% CI, 0.58–0.75); overweight, PR=0.62 (95% CI, 0.56–0.70); and obesity, PR=0.75 (95% CI, 0.67–0.85).

Conclusion

A higher prevalence of multimorbidity was found among obese women who were 60 years of age or older. Schooling was an associated factor regardless of BMI.

Narrative review of the influence of high-intensity interval training on adolescents' bone health: commentary and perspectives

Although several benefits have been associated to high-intensity interval training (HIIT), there is a lack of clarity on the HIIT effects in adolescents, especially on bone health outcomes. To address this gap, our research aimed to perform a systematic review, which focus on the influence of HIIT on adolescents' bone health. Our search strategy was conducted on three databases (PubMed, SCOPUS, and Embase). For our review, we included articles with the following characteristics: (I) sample consisting of adolescents (10-19 years old), (II) HIIT interventions; and (III) assessment of bone health outcomes. Longitudinal and clinical trials studies with no language and year of publications restrictions were eligible to be included. A total of 63 eligible studies were identified. After removing the duplicates and screening the titles and abstracts, six articles remained to be read in full text. However, none of the articles met our criteria. Studies in which no article meets the eligibility criteria are also essential and need to be shared with the academic community because it may stimulate appropriate future investigations in this field. This lack in the review results highlights the need for further epidemiological research focusing on this topic, including high quality, large scale, and longitudinal studies, as well as randomized controlled trials to confirm or refute efficacy.

High prevalence of musculoskeletal pain in individuals with severe obesity: sites, intensity, and associated factors

Background

Musculoskeletal pain is associated with obesity; however, information on factors associated with pain in adults with obesity and severe obesity is limited. The purpose of this study was to assess the prevalence of musculoskeletal pain by site and intensity of pain and associated factors in individuals with severe obesity (body mass index ≥ 35.0 kg/m²).

Methods

Baseline data from the DieTBra Trial study evaluating pain symptoms in nine body regions over the last seven days using the Nordic Questionnaire on Musculoskeletal Symptoms and Numerical Pain Scale. The variables analyzed using multiple Poisson regression with hierarchical analysis were: sociodemographic, lifestyle, food consumption, clinical, and anthropometric, and the outcome was moderate and intense pain.

Results

In 150 participants, there was a high prevalence of ankle and foot pain (68.7%), lower back pain (62.7%), pain in the knees (53.3%) and upper back pain (52.0%), with a predominance of intense pain. Factors associated with pain according to specific sites were: type 2 diabetes with hand/wrist pain; sedentary time with hip pain; insomnia with pain in the hip and knee; edema in the lower limbs with pain in the lower back and ankles/feet; degree of obesity with ankle/foot pain; and percentage of total fat with ankle/foot pain.

Conclusions

There was a high prevalence of pain and intense pain in individuals with severe obesity and an association with clinical variables, the degree of obesity, and sedentary lifestyle.

Thyroid Nodules in Severely Obese Patients: Frequency and Risk of Malignancy on Ultrasonography

Background: We aimed to compare the thyroid ultrasonographic findings of severely obese versus nonobese individuals, and the frequency, characteristics, and risk of malignancy in detected nodules.Design: Case-control study including 67 adults with severe obesity (body mass index [BMI] ≥ 35 kg/m²) and 67 nonobese controls (BMI < 30 kg/m²). The participants underwent ultrasound evaluation of the thyroid and cervical subcutaneous tissue. The risk of malignancy in detected nodules was determined using the American Thyroid Association (ATA) 2015 and the Thyroid Imaging Reporting and Data System (TI-RADS) classifications. Fine-needle aspiration biopsy (FNAB) was performed in nodules for which the procedure was recommended according to the ATA-2015 or TI-RADS criteria, and the cytological evaluation followed the Bethesda classification.Results: The mean BMI values in the case and control groups were 47.0 ± 6.1 kg/m² and 22.8 ± 2.7 kg/m², respectively. There were no differences between groups regarding sex, age, total T3, and antiperoxidase (antiTPO) antibody positivity. When compared with controls, severely obese individuals showed a greater frequency of parenchymal hypoechogenicity (p = 0.042), cervical subcutaneous tissue thickness (p < 0.001), overall frequency of thyroid nodules (p = 0.038), and frequency of multiple nodules (p = 0.013). No significant differences were observed in terms of risk of nodular malignancy according to both the ATA-2015 and TI-RADS classifications in severely obese compared with nonobese individuals.Conclusions: Severely obese individuals (versus nonobese controls) presented increased parenchymal hypoechogenicity and frequency of thyroid nodules on ultrasonographic evaluation. However, no significant differences were observed in terms of risk of nodular malignancy between both groups according to the ATA-2015 and TI-RADS criteria. Thus, ultrasonographic thyroid screening of severely obese individuals is not justified.